Provided by Tiger Trade Technology Pte. Ltd.

Oppenheimer

85.89
+2.392.86%
Volume:4.87K
Turnover:412.07K
Market Cap:919.65M
PE:6.59
High:85.89
Open:84.24
Low:83.87
Close:83.50
52wk High:94.10
52wk Low:49.26
Shares:10.71M
Float Shares:5.93M
Volume Ratio:0.71
T/O Rate:0.08%
Dividend:0.72
Dividend Rate:0.84%
EPS(TTM):13.04
EPS(LYR):13.04
ROE:16.02%
ROA:4.16%
PB:0.93
PE(LYR):6.59

Loading ...

Lindblad Expeditions Initiated at Outperform by Oppenheimer

Dow Jones
·
Mar 16

Lindblad Expeditions initiated with an Outperform at Oppenheimer

TIPRANKS
·
Mar 16

Oppenheimer Initiates Opus Genetics at Outperform With $10 Price Target

MT Newswires Live
·
Mar 16

Oppenheimer Adjusts PT on Stellus Capital Investment to $12 From $13, Maintains Perform Rating

MT Newswires Live
·
Mar 16

Opus Genetics initiated with an Outperform at Oppenheimer

TIPRANKS
·
Mar 16

Oppenheimer Adjusts PT on CION Investment to $10 From $11, Maintains Perform Rating

MT Newswires Live
·
Mar 16

Ulta Beauty Is Maintained at Outperform by Oppenheimer

Dow Jones
·
Mar 14

Pharming Group Price Target Cut to $41.00/Share From $42.00 by Oppenheimer

Dow Jones
·
Mar 14

Jefferies Financial Is Maintained at Outperform by Oppenheimer

Dow Jones
·
Mar 14

Nektar price target raised to $140 from $115 at Oppenheimer

TIPRANKS
·
Mar 14

Oppenheimer Adjusts Pharming Group NV Price Target to $41 From $42, Maintains Outperform Rating

MT Newswires Live
·
Mar 13

Oppenheimer Adjusts Price Target on Jefferies Financial to $74 From $97, Maintains Outperform Rating

MT Newswires Live
·
Mar 13

Oppenheimer Adjusts Price Target on KLA to $1,900 From $1,800, Maintains Outperform Rating

MT Newswires Live
·
Mar 13

Oppenheimer Adjusts Price Target on Ulta Beauty to $650 From $750, Maintains Outperform Rating

MT Newswires Live
·
Mar 13

Ulta Beauty price target lowered to $650 from $750 at Oppenheimer

TIPRANKS
·
Mar 13

KLA Corp. price target raised to $1,900 from $1,800 at Oppenheimer

TIPRANKS
·
Mar 13

Corvus Pharmaceuticals price target raised to $33 from $32 at Oppenheimer

TIPRANKS
·
Mar 13

Pharming price target lowered to $41 from $42 at Oppenheimer

TIPRANKS
·
Mar 13

Oppenheimer Remains a Hold on Pliant Therapeutics (PLRX)

TIPRANKS
·
Mar 13

The Ensign Group to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 19, 2026

GlobeNewswire
·
Mar 13